Search research articles
Contact Us
Filters
Showing results (201-210 of 320) with videos related to
Page
of 32
Sort By:
Leukemia
|
November 1, 1994
Karyotype and prognosis in non-Hodgkin lymphoma
H Pirc-Danoewinata, A Chott, E Onderka, et al.
European Journal of Cancer & Clinical Oncology
|
July 1, 1988
Escalating dose regimen of intraperitoneal mitoxantrone: phase I study--clinical and pharmacokinetic evaluation
B Blöchl-Daum, H G Eichler, H Rainer, et al.
Onkologie
|
February 1, 1987
Phase-I study of intraperitoneal mitoxantrone--clinical and pharmacokinetic evaluation
B Blöchl-Daum, H G Eichler, H Rainer, et al.
Cancer Research
|
July 29, 1998
Interstitial methotrexate kinetics in primary breast cancer lesions
M Müller, M Brunner, R Schmid, et al.
Anti-Cancer Drugs
|
June 1, 2000
Vinorelbine and interferon-alpha2c as second-line therapy in metastatic renal cell carcinoma
M Schmidinger, G G Steger, A C Budinsky, et al.
Annals of Surgical Oncology
|
December 25, 2019
Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival
K Wimmer, M Bolliger, Z Bago-Horvath, et al.
The Journal of Laboratory and Clinical Medicine
|
June 1, 2001
Reverse transcriptase template switching during reverse transcriptase-polymerase chain reaction: artificial generation of deletions in ribonucleotide reductase mRNA
R M Mader, W M Schmidt, R Sedivy, et al.
Journal of Plant Physiology
|
April 11, 2017
Propagation and some physiological effects of Citrus bark cracking viroid and Apple fruit crinkle viroid in multiple infected hop (Humulus lupulus L.)
J Matoušek, K Siglová, J Jakše, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
Her2 and progesterone receptor status are not predictive of response to fulvestrant treatment
Rupert Bartsch, Catharina Wenzel, Gabriela Altorjai, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1997
The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinoma
G G Steger, M F Gnant, M P Djavanmard, et al.
Page
of 32
Search research articles
Search
Showing results (201-210 of 320) with videos related to
Sort By:
Page
of 32
Leukemia
|
November 1, 1994
Karyotype and prognosis in non-Hodgkin lymphoma
H Pirc-Danoewinata, A Chott, E Onderka, et al.
European Journal of Cancer & Clinical Oncology
|
July 1, 1988
Escalating dose regimen of intraperitoneal mitoxantrone: phase I study--clinical and pharmacokinetic evaluation
B Blöchl-Daum, H G Eichler, H Rainer, et al.
Onkologie
|
February 1, 1987
Phase-I study of intraperitoneal mitoxantrone--clinical and pharmacokinetic evaluation
B Blöchl-Daum, H G Eichler, H Rainer, et al.
Cancer Research
|
July 29, 1998
Interstitial methotrexate kinetics in primary breast cancer lesions
M Müller, M Brunner, R Schmid, et al.
Anti-Cancer Drugs
|
June 1, 2000
Vinorelbine and interferon-alpha2c as second-line therapy in metastatic renal cell carcinoma
M Schmidinger, G G Steger, A C Budinsky, et al.
Annals of Surgical Oncology
|
December 25, 2019
Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival
K Wimmer, M Bolliger, Z Bago-Horvath, et al.
The Journal of Laboratory and Clinical Medicine
|
June 1, 2001
Reverse transcriptase template switching during reverse transcriptase-polymerase chain reaction: artificial generation of deletions in ribonucleotide reductase mRNA
R M Mader, W M Schmidt, R Sedivy, et al.
Journal of Plant Physiology
|
April 11, 2017
Propagation and some physiological effects of Citrus bark cracking viroid and Apple fruit crinkle viroid in multiple infected hop (Humulus lupulus L.)
J Matoušek, K Siglová, J Jakše, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
Her2 and progesterone receptor status are not predictive of response to fulvestrant treatment
Rupert Bartsch, Catharina Wenzel, Gabriela Altorjai, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1997
The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinoma
G G Steger, M F Gnant, M P Djavanmard, et al.
Page
of 32